BMC Cancer

SJR Rank #3,780H-index: 180SJR: 1.172Best quartile: Q2Open AccessAPC: US$3,390Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • Cancer ResearchQ2
  • GeneticsQ2
  • OncologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisBreast Cancer Treatment StudiesCancer survivorship and careGlobal Cancer Incidence and ScreeningCancer Cells and MetastasisHead and Neck Cancer StudiesLung Cancer Treatments and MutationsInflammatory Biomarkers in Disease PrognosisHepatocellular Carcinoma Treatment and Prognosis

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs01500300045006000

Documents per Year

202220250500100015002000

Detailed Information

ISSN

1471-2407

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

4.05

References per Document

43.10

Coverage

2001-2026

Scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.

Metrics from SCImago Journal Rank 2025. View on SCImago